Search Within

Joachim Yahalom

  1. "Molecular Pharmacology and Chemistry Program Faculty"
Formats
  1. Journal Article (15)
  2. Meeting Abstract (10)
  3. Conference Paper (3)
  4. Book Section (1)
Groups
  1. Molecular Pharmacology and Chemistry Program Faculty (29)
  2. Radiation Oncology, Department of (29)
  3. Sloan Kettering Institute Faculty (29)
  4. Survivorship Research (29)
  5. GSK Faculty (22)
  6. Department of Medicine (18)

More Groups

People
  1. Zvi Fuks (14)
  2. Bayard Clarkson (10)
  3. David Straus (8)
  4. Subhash Gulati (7)
  5. Jane Myers (5)
  6. Maria Palomba (5)

More People

Years
  1. 2020 (1)
  2. 2019 (3)
  3. 2018 (1)
  4. 2007 (1)
  5. 2006 (1)
  6. 1998 (2)

More Years

Publications
  1. Blood (3)
  2. International Journal of Radiation Oncology, Biology, Physics (3)
  3. Journal of Clinical Oncology (3)
  4. Proceedings of the American Association for Cancer Research Annual Meeting (3)
  5. Bone Marrow Transplantation (2)
  6. Cancer (2)

More Publications

Publishers
  1. American Association for Cancer Research (4)
  2. Nature Publishing Group (4)
  3. American Society of Clinical Oncology (3)
  4. American Society of Hematology (3)
  5. Elsevier Inc. (3)
  6. Wiley Blackwell (3)

More Publishers

Results (29)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Early experience using salvage radiotherapy for relapsed/refractory non-Hodgkin lymphomas after CD19 chimeric antigen receptor (CAR) T cell therapy
    Journal Article

    Imber, B. S.; Sadelain, M.; DeSelm, C.; Batlevi, C.; Brentjens, R. J.; Dahi, P. B.; Giralt, S.; Park, J. H.; Sauter, C.; Scordo, M.; more...
    British Journal of Haematology (2020)

    Fulltext@MSK | Save
  • Early experience using radiotherapy as a salvage treatment for relapsed or refractory non-Hodgkin lymphomas following CD19 chimeric antigen receptor modified T-cell therapy
    Meeting Abstract

    Imber, B.; Palomba, M. L.; DeSelm, C.; Dahi, P. B.; Sauter, C. S.; Scordo, M.; Batlevi, C. L.; Park, J. H.; Shah, G. L.; Giralt, S. A.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • MSKCC early experience using radiotherapy as a bridging strategy for relapsed diffuse large B cell lymphoma before CD19 CAR T therapy
    Meeting Abstract

    Imber, B.; Palomba, M. L.; DeSelm, C.; Batlevi, C. L.; Dahi, P. B.; Giralt, S. A.; Noy, A.; Park, J. H.; Sauter, C. S.; Scordo, M.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • MSKCC early experience using radiotherapy as a bridging strategy for relapsed diffuse large B cell lymphoma before CD19 CAR T therapy
    Meeting Abstract

    Imber, B. S.; Palomba, M. L.; DeSelm, C.; Batlevi, C.; Dahi, P. B.; Giralt, S.; Noy, A. M.; Park, J. H.; Sauter, C. S.; Scordo, M.; more...
    Hematological Oncology (2019)

    Fulltext@MSK | Save
  • Low-dose radiation conditioning enables CAR T cells to mitigate antigen escape
    Journal Article

    DeSelm, C.; Palomba, M. L.; Yahalom, J.; Hamieh, M.; Eyquem, J.; Rajasekhar, V. K.; Sadelain, M.
    Molecular Therapy (2018)

    Fulltext@MSK | Save
  • NCCN Task Force report: Positron emission tomography (PET)/computed tomography (CT) scanning in cancer
    Journal Article

    Podoloff, D. A.; Advani, R. H.; Allred, C.; Benson, A. B. 3rd; Brown, E.; Burstein, H. J.; Carlson, R. W.; Coleman, R. E.; Czuczman, M. S.; Delbeke, D.; more...
    Journal of the National Comprehensive Cancer Network (2007)

    Fulltext@MSK | Save
  • Inaccuracy of fixed threshold segmentation for PET
    Meeting Abstract

    Kirov, A.; Danford, C.; Schmidtlein, C.; Yorke, E.; Yahalom, J.; Kalaigian, H.; Hu, Y.; Larson, S.; Humm, J.; Amols, H.
    Medical Physics (2006)

    Fulltext@MSK | Save
  • Serial gallium scans in patients with bulky early stage Hodgkin's disease treated with chemotherapy and irradiation predict outcome
    Meeting Abstract

    Rini, J.; Yeung, H.; Macapinlac, H.; Myers, J.; Larson, S.; Yahalom, J.; Glassman, J.; Straus, D.
    Blood (1998)

    Fulltext@MSK | Save
  • Overexpression of basic fibroblast growth factor in MCF-7 human breast cancer cells: Lack of correlation between inhibition of cell growth and MAP kinase activation
    Journal Article

    Wieder, R.; Fenig, E.; Wang, H.; Wang, Q.; Paglin, S.; Menzel, T.; Gabrilove, J.; Fuks, Z.; Yahalom, J.
    Journal of Cellular Physiology (1998)

    Fulltext@MSK | Save
  • Basic fibroblast growth factor confers growth inhibition and mitogen-activated protein kinase activation in human breast cancer cells
    Journal Article

    Fenig, E.; Wieder, R.; Paglin, S.; Wang, H.; Persaud, R.; Haimovitz-Friedman, A.; Fuks, Z.; Yahalom, J.
    Clinical Cancer Research (1997)

    Fulltext@MSK | Save